Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 3 2Phase 2/3 2Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Unknown 3Withdrawn 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Uterine Cervical Dysplasia 3

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Unknown × Imiquimod × Clear all
NCT04859361 2021-05-03

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

University Medical Centre Maribor

Phase NA Unknown
104 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT02917746 2018-08-16

TOPIC-3

Maastricht University Medical Center

Phase NA Unknown
120 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT03206138 2017-07-02

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Seoul St. Mary's Hospital

Phase NA Unknown
50 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡